{ }
Silicon Valley's elite are increasingly obsessed with achieving immortality, employing radical biohacking methods to extend their lives. This trend is exemplified by figures like Bryan Johnson, who promotes extreme health practices and community-focused initiatives like "Don't Die" dinners. The conversation explores the implications of these pursuits for society at large.
23andMe reported a revenue decline to $44.1 million for the fiscal second quarter, down from $50 million last year, alongside a net loss of $59.1 million. The company plans to cut 40% of its workforce, discontinue its therapeutics business, and is exploring strategic options to maximize value. CEO Anne Wojcicki aims to refocus on the core consumer business while considering taking the company private.
23andMe faces potential bankruptcy, raising concerns over the fate of customer DNA data, particularly for Swiss users, where genetic data is generally well protected. Despite claims of data security, the company’s policies allow for data sale during acquisitions, and past breaches have compromised sensitive information. With a significant drop in value and management turmoil, the future of 23andMe and its handling of genetic data remains uncertain.
23andMe has appointed three new independent directors—Andre Fernandez, Jim Frankola, and Mark Jensen—following the abrupt resignation of all seven previous directors due to disagreements over the company's strategic direction. The new board members will serve on the audit and compensation committees, with Jensen as the lead independent director. The company has faced challenges since going public in 2021, including a significant drop in stock value, prompting discussions about taking the company private.
23andMe, once valued at $6 billion, has seen its worth plummet by 98% and is at risk of being delisted from Nasdaq after the resignation of all independent board members. The company, which aimed to innovate genetic testing and drug discovery, reported a $312 million net loss in 2023, compounded by privacy concerns following a data breach affecting nearly 7 million customers. CEO Anne Wojcicki's proposal to take the company private was rejected, and with a looming deadline to maintain its share price above $1, 23andMe faces significant challenges ahead.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

MachinaCore is a highly modular and scalable system that allows users to build custom widgets and tools tailored to their specific financial data needs, while seamlessly integrating with other MachinaLabs products, like Machinary, MachinaAI Modules and MachinaTrader.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.